Vered Klinghofer

3.0k total citations
27 papers, 1.3k citations indexed

About

Vered Klinghofer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Vered Klinghofer has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Vered Klinghofer's work include Nitric Oxide and Endothelin Effects (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). Vered Klinghofer is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). Vered Klinghofer collaborates with scholars based in United States, United Kingdom and Canada. Vered Klinghofer's co-authors include Vincent L. Giranda, Jennifer S. Pollock, Xuesong Liu, Eric F. Johnson, Ulrich Förstermann, Gui‐Dong Zhu, Thomas D. Penning, Saul H. Rosenberg, Gerald P. Budzik and Viraj B. Gandhi and has published in prestigious journals such as Science, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Vered Klinghofer

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vered Klinghofer United States 21 580 372 338 288 113 27 1.3k
Andrew S. Tasker United States 20 681 1.2× 482 1.3× 230 0.7× 185 0.6× 114 1.0× 45 1.4k
Barry G. Shearer United States 18 1.0k 1.8× 326 0.9× 150 0.4× 321 1.1× 139 1.2× 31 1.6k
Laurie Churchill United States 13 686 1.2× 260 0.7× 263 0.8× 208 0.7× 66 0.6× 20 1.3k
Loredana Vesci Italy 30 1.1k 2.0× 558 1.5× 563 1.7× 163 0.6× 70 0.6× 73 2.0k
Sonia Martı́nez Spain 20 1.1k 1.8× 244 0.7× 341 1.0× 352 1.2× 139 1.2× 49 1.6k
Yuanjun He United States 18 1.2k 2.1× 269 0.7× 203 0.6× 301 1.0× 125 1.1× 34 1.8k
Alan Hruza United States 15 650 1.1× 212 0.6× 190 0.6× 266 0.9× 35 0.3× 23 1.2k
John D. Elliott United States 26 618 1.1× 840 2.3× 164 0.5× 491 1.7× 47 0.4× 66 1.9k
Mui Cheung United States 21 981 1.7× 709 1.9× 433 1.3× 103 0.4× 170 1.5× 40 2.1k
James Fossetta United States 15 364 0.6× 176 0.5× 170 0.5× 294 1.0× 43 0.4× 25 935

Countries citing papers authored by Vered Klinghofer

Since Specialization
Citations

This map shows the geographic impact of Vered Klinghofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vered Klinghofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vered Klinghofer more than expected).

Fields of papers citing papers by Vered Klinghofer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vered Klinghofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vered Klinghofer. The network helps show where Vered Klinghofer may publish in the future.

Co-authorship network of co-authors of Vered Klinghofer

This figure shows the co-authorship network connecting the top 25 collaborators of Vered Klinghofer. A scholar is included among the top collaborators of Vered Klinghofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vered Klinghofer. Vered Klinghofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingwei, Michael J. Mitten, Loren Lasko, et al.. (2012). Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(24). 7615–7622. 12 indexed citations
2.
Gandhi, Viraj B., Yan Luo, Xuesong Liu, et al.. (2009). Discovery and SAR of substituted 3-oxoisoindoline-4-carboxamides as potent inhibitors of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 20(3). 1023–1026. 29 indexed citations
3.
Tong, Yunsong, Kent D. Stewart, Sheela A. Thomas, et al.. (2008). Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling. Bioorganic & Medicinal Chemistry Letters. 18(19). 5206–5208. 52 indexed citations
4.
Liu, Xuesong, Yan Shi, Ran Guan, et al.. (2008). Potentiation of Temozolomide Cytotoxicity by Poly(ADP)Ribose Polymerase Inhibitor ABT-888 Requires a Conversion of Single-Stranded DNA Damages to Double-Stranded DNA Breaks. Molecular Cancer Research. 6(10). 1621–1629. 61 indexed citations
5.
Zhu, Gui‐Dong, Viraj B. Gandhi, Jianchun Gong, et al.. (2008). Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent. Bioorganic & Medicinal Chemistry Letters. 18(14). 3955–3958. 42 indexed citations
6.
Zhu, Gui‐Dong, Jianchun Gong, Viraj B. Gandhi, et al.. (2007). Design and synthesis of pyridine–pyrazolopyridine-based inhibitors of protein kinase B/Akt. Bioorganic & Medicinal Chemistry. 15(6). 2441–2452. 58 indexed citations
7.
Zhu, Gui‐Dong, Viraj B. Gandhi, Jianchun Gong, et al.. (2006). Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers. Bioorganic & Medicinal Chemistry Letters. 16(13). 3424–3429. 42 indexed citations
8.
Thomas, Sheela A., Tongmei Li, Keith W. Woods, et al.. (2006). Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinase. Bioorganic & Medicinal Chemistry Letters. 16(14). 3740–3744. 11 indexed citations
9.
Shi, Yan, Xuesong Liu, Edward K. Han, et al.. (2005). Optimal Classes of Chemotherapeutic Agents Sensitized by Specific Small-Molecule Inhibitors of Akt In Vitro and In Vivo. Neoplasia. 7(11). 992–1000. 35 indexed citations
10.
Wendt, Michael, William J. McClellan, Todd W. Rockway, et al.. (2004). Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3063–3068. 24 indexed citations
11.
Bruncko, Milan, William J. McClellan, Michael Wendt, et al.. (2004). Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 15(1). 93–98. 19 indexed citations
12.
Luo, Yan, Richard A. Smith, Ran Guan, et al.. (2004). Pseudosubstrate Peptides Inhibit Akt and Induce Cell Growth Inhibition. Biochemistry. 43(5). 1254–1263. 44 indexed citations
13.
Nienaber, V., Donald J. Davidson, Rohinton Edalji, et al.. (2000). Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite. Structure. 8(5). 553–563. 46 indexed citations
14.
Stewart, Kent D., et al.. (1998). Discovery of a new cyclooxygenase-2 lead compound through 3-D database searching and combinatorial chemistry. Bioorganic & Medicinal Chemistry Letters. 8(5). 529–534. 25 indexed citations
15.
Nakane, Masaki, Vered Klinghofer, Jane Kuk, et al.. (1995). Novel potent and selective inhibitors of inducible nitric oxide synthase.. Molecular Pharmacology. 47(4). 831–834. 112 indexed citations
16.
Tracey, W. Ross, et al.. (1995). The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1295–1299. 71 indexed citations
17.
Nakane, Masaki, Jennifer S. Pollock, Vered Klinghofer, et al.. (1995). Functional Expression of Three Isoforms of Human Nitric Oxide Synthase in Baculovirus-Infected Insect Cells. Biochemical and Biophysical Research Communications. 206(2). 511–517. 34 indexed citations
18.
Boyd, Steven A., Anthony K. L. Fung, William R. Baker, et al.. (1994). Nonpeptide Renin Inhibitors with Good Intraduodenal Bioavailability and Efficacy in Dog. Journal of Medicinal Chemistry. 37(19). 2991–3007. 29 indexed citations
19.
Wessale, Jerry L., Samuel V. Calzadilla, Steven A. Boyd, et al.. (1993). Cardiovascular Effects and Hemodynamic Mechanism of Action of the Novel, Nonpeptidic Renin Inhibitor A-74273 in Dogs. Journal of Cardiovascular Pharmacology. 22(4). 644–652. 8 indexed citations
20.
Verburg, Kenneth M., James S. Polakowski, Peter Kovar, et al.. (1993). Effects of High Doses of A-74273, a Novel Nonpeptidic and Orally Bioavailable Renin Inhibitor. Journal of Cardiovascular Pharmacology. 21(1). 149–155. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew S. Tasker Breakdown of academic impact, for papers by Barry G. Shearer Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by Loredana Vesci Breakdown of academic impact, for papers by Sonia Martı́nez Breakdown of academic impact, for papers by Yuanjun He Breakdown of academic impact, for papers by Alan Hruza Breakdown of academic impact, for papers by John D. Elliott Breakdown of academic impact, for papers by Mui Cheung Breakdown of academic impact, for papers by James Fossetta
Rankless by CCL
2026